Literature DB >> 24308012

Expression of VHL Causes Three-Dimensional Morphological Changes in Renal Cells Indicative of Proximal Tubule Differentiation.

Shivannah S Chiatar, Ogechukwu P Eze, Alan R Schoenfeld.   

Abstract

Mutations in the von Hippel-Lindau (VHL) tumor suppressor gene are responsible for the VHL hereditary cancer syndrome, and are associated with the majority of clear cell renal cell carcinomas. In this study, scanning electron microscopy of VHL-negative renal carcinoma cells was utilized to examine the effects of VHL re-expression on the morphology of these cells. Significant differences were observed between the morphology of VHL-negative control cells and those with reintroduced VHL, with VHL expression mediating an apical surface that mounded upward, as opposed to the flat surfaces seen with VHL-negative cells. In long term cultures, rounded VHL-expressing cells grew in clusters on top the monolayer, and microvilli were observed on the apical face of these cells, in a manner suggestive of proximal tubule differentiation. In contrast, VHL-negative cells remained flat and did not develop microvilli in long-term cultures. Since VHL is a key member of an ubiquitin E3 ligase complex whose best known target is hypoxia-inducible factor alpha (HIF-α), we looked at the effects of HIF-α expression on cell morphology. Knockdown of HIF-2α in cells that only express this isoform had no effect on the morphology of the cells. These results indicate that VHL expression directs three dimensional morphological changes in renal cells indicative of differentiation, and while dysregulation of HIF-α may be necessary for tumorigenesis following VHL loss, it is not the major determinant of these VHL-mediated morphological changes.

Entities:  

Keywords:  Microvilli; Renal cell carcinoma; Renal cells

Year:  2013        PMID: 24308012      PMCID: PMC3845820          DOI: 10.4172/2168-9296.1000118

Source DB:  PubMed          Journal:  Cell Dev Biol        ISSN: 2168-9296


  20 in total

1.  Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein.

Authors:  M E Cockman; N Masson; D R Mole; P Jaakkola; G W Chang; S C Clifford; E R Maher; C W Pugh; P J Ratcliffe; P H Maxwell
Journal:  J Biol Chem       Date:  2000-08-18       Impact factor: 5.157

2.  VHL induces renal cell differentiation and growth arrest through integration of cell-cell and cell-extracellular matrix signaling.

Authors:  E J Davidowitz; A R Schoenfeld; R D Burk
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

3.  Formation of primary cilia in the renal epithelium is regulated by the von Hippel-Lindau tumor suppressor protein.

Authors:  Miguel A Esteban; Sarah K Harten; Maxine G Tran; Patrick H Maxwell
Journal:  J Am Soc Nephrol       Date:  2006-06-14       Impact factor: 10.121

4.  The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.

Authors:  P H Maxwell; M S Wiesener; G W Chang; S C Clifford; E C Vaux; M E Cockman; C C Wykoff; C W Pugh; E R Maher; P J Ratcliffe
Journal:  Nature       Date:  1999-05-20       Impact factor: 49.962

5.  Alternate choice of initiation codon produces a biologically active product of the von Hippel Lindau gene with tumor suppressor activity.

Authors:  C Blankenship; J G Naglich; J M Whaley; B Seizinger; N Kley
Journal:  Oncogene       Date:  1999-02-25       Impact factor: 9.867

6.  Clinical features and natural history of von Hippel-Lindau disease.

Authors:  E R Maher; J R Yates; R Harries; C Benjamin; R Harris; A T Moore; M A Ferguson-Smith
Journal:  Q J Med       Date:  1990-11

7.  Primary cilium formation requires von hippel-lindau gene function in renal-derived cells.

Authors:  Mallory S Lutz; Robert D Burk
Journal:  Cancer Res       Date:  2006-07-15       Impact factor: 12.701

8.  Regulation of E-cadherin expression by VHL and hypoxia-inducible factor.

Authors:  Miguel A Esteban; Maxine G B Tran; Sarah K Harten; Peter Hill; Maria C Castellanos; Ashish Chandra; Raju Raval; Tim S O'brien; Patrick H Maxwell
Journal:  Cancer Res       Date:  2006-04-01       Impact factor: 12.701

9.  Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein.

Authors:  O Iliopoulos; A P Levy; C Jiang; W G Kaelin; M A Goldberg
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

10.  A second major native von Hippel-Lindau gene product, initiated from an internal translation start site, functions as a tumor suppressor.

Authors:  A Schoenfeld; E J Davidowitz; R D Burk
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

View more
  3 in total

1.  In situ, dual-mode monitoring of organ-on-a-chip with smartphone-based fluorescence microscope.

Authors:  Soohee Cho; Argel Islas-Robles; Ariana M Nicolini; Terrence J Monks; Jeong-Yeol Yoon
Journal:  Biosens Bioelectron       Date:  2016-07-07       Impact factor: 10.618

2.  Effects of preset sequential administrations of sunitinib and everolimus on tumour differentiation in Caki-1 renal cell carcinoma.

Authors:  C Dos Santos; A Tijeras-Raballand; M Serova; S Sebbagh; K Slimane; S Faivre; A de Gramont; E Raymond
Journal:  Br J Cancer       Date:  2014-11-25       Impact factor: 7.640

3.  Everolimus affects vasculogenic mimicry in renal carcinoma resistant to sunitinib.

Authors:  Maria Serova; Annemilaï Tijeras-Raballand; Celia Dos Santos; Matthieu Martinet; Cindy Neuzillet; Alfred Lopez; Dianne C Mitchell; Brad A Bryan; Guillaume Gapihan; Anne Janin; Guilhem Bousquet; Maria Eugenia Riveiro; Ivan Bieche; Sandrine Faivre; Eric Raymond; Armand de Gramont
Journal:  Oncotarget       Date:  2016-06-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.